Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS randomized clinical trial

JAMA

Volumn 311, Issue 5, 2014, Pages 479-489

  He, Jiang ^a,b,c   Zhang, Yonghong ^a,b   Xu, Tan ^a   Zhao, Qi ^b   Wang, Dali ^d   Chen, Chung Shiuan ^b   Tong, Weijun ^a   Liu, Changjie ^e   Xu, Tian ^a   Ju, Zhong ^f   Peng, Yanbo ^d   Peng, Hao ^a   Li, Qunwei ^g   Geng, Deqin ^h   Zhang, Jintao ⁱ   Li, Dong ^j   Zhang, Fengshan ^k   Guo, Libing ^l   Sun, Yingxian ^m   Wang, Xuemei ⁿ   Cui, Yong ^o   Li, Yongqiu ^p   Ma, Dihui ^q   Yang, Guang ^r   Gao, Yanjun ^s   Yuan, Xiaodong ^t   Bazzano, Lydia A ^b,c   Chen, Jing ^b,c   more..

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HEBEI UNITED UNIVERSITY   (China)

^e Yutian County Hospital   (China)

^f The First People s Hospital of Kerqin District   (China)

^g SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^h XUZHOU MEDICAL UNIVERSITY   (China)

ⁱ The 88th Hospital of PLA   (China)

^j Feicheng City People's Hospital   (China)

^k Department of Ophthalmology   (China)

^l Siping Central Hospital   (China)

^m CHINA MEDICAL UNIVERSITY   (China)

ⁿ Affiliated Jilin Hospital of Jilin University   (China)

^o Department of Neurology   (China)

^p Hospital of Workers   (China)

^q JILIN UNIVERSITY   (China)

^r Second People's Hospital of Huaian   (China)

^s CHENGDE MEDICAL COLLEGE   (China)

^t Kailuan General Hospital Zhaogezhuang Hospital   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN ISCHEMIA; CHINA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISABILITY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FIBRINOLYSIS; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SENSITIVITY ANALYSIS; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN ISCHEMIA; DISABLED PERSONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT DISCHARGE; SINGLE-BLIND METHOD; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893596863     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.282543     Document Type: Article

References (35)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2095-2128.
2. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet. 2003;362(9395):1527-1535.
3. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
4. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041.
5. Benavente OR, Coffey CS, Conwit R, et al; SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial [published correction appears in Lancet. 2013;382(9891):506]. Lancet. 2013;382(9891):507-515.
6. Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011;305(9):913-922.
7. Jauch EC, Saver JL, Adams HP Jr, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.
8. Tyrrell P, Swain S, Rudd A; Acute Stroke and TIA Guideline Development Group. NICE guideline on acute stroke and TIA: commentary. Heart. 2009;95(10):843-845.
9. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1):32-38. (Pubitemid 44869006)
10. Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35(2):520-526.
11. Chamorro A, Vila N, Ascaso C, Elices E, Schonewille W, Blanc R. Blood pressure and functional recovery in acute ischemic stroke. Stroke. 1998;29(9):1850-1853. (Pubitemid 28399976)
12. Zhang Y, Reilly KH, Tong W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26(7):1446-1452.
13. China National Guidelines for Prevention and Treatment of Cerebrovascular Diseases Committee. China National Guidelines for Prevention and Treatment of Cerebrovascular Diseases. Beijing, China: People's Medical Publishing House; 2005.
14. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864-870. (Pubitemid 19188240)
15. Pickering TG, Hall JE, Appel LJ, et al; Council on High Blood Pressure Research Professional and Public Education Subcommittee, American Heart Association. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005;7(2):102-109.
16. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497-1500. (Pubitemid 19005804)
17. Bath PM, Lees KR, Schellinger PD, et al; European Stroke Organisation Outcomes Working Group. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43(4):1171-1178.
18. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Manual of Operations. University of Texas Coordinating Center for Clinical Trials website. https://ccct.sph.uth.tmc.edu/allhatoutreach/. Accessed August 8, 2013.
19. Weaver CS, Leonardi-Bee J, Bath-Hextall FJ, Bath PMW. Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome. Stroke. 2004;35(5):1216-1224. (Pubitemid 38543546)
20. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349(9066):1641-1649.
21. Wilcoxon F. Individual comparisons by ranking methods. Biomed Bull. 1945;1:80-83.
22. McCullagh P. Regression models for ordinal data (with discussion). J R Stat Soc B. 1980;42:109-142.
23. Zhang J, Yang J, Zhang C, Jiang X, Zhou H, Liu M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2012;5(5):CD001928.
24. Ahmed N, Näsman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000;31(6):1250-1255. (Pubitemid 30351241)
25. Kaste M, Fogelholm R, Erilä T, et al. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke. 1994;25(7):1348-1353. (Pubitemid 24198578)
26. Schrader J, Lüders S, Kulschewski A, et al; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34(7):1699-1703. (Pubitemid 36842630)
27. Potter JF, Robinson TG, Ford GA, et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8(1):48-56.
28. Robinson TG, Potter JF, Ford GA, et al; COSSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9(8):767-775.
29. Sandset EC, Bath PM, Boysen G, et al; SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741-750.
30. Anderson CS, Heeley E, Huang Y, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365.
31. Lakshminarayan K, Peacock JM, Luepker RV, Tsai AW. Thrombolytic treatment after acute ischemic stroke results from the Minnesota Stroke Registry and opportunities to improve care. J Vasc Interv Neurol. 2008;1(3):87-88.
32. Allen NB, Myers D, Watanabe E, et al. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009;27(3):254-258.
33. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-2488.
34. Wang Y, Liao X, Zhao X, et al; China National Stroke Registry Investigators. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011;42(6):1658-1664.
35. Wang PL, Zhao XQ, Du WL, et al; China National Stroke Registry (CNSR) Investigators. In-hospital medical complications associated with patient dependency after acute ischemic stroke: data from the China National Stroke Registry. Chin Med J (Engl). 2013;126(7):1236-1241.